Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.13p
   
  • Change Today:
      0.075p
  • 52 Week High: 14.13
  • 52 Week Low: 1.90
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 142,606
  • Market Cap: £4.14m
  • RiskGrade: 435

Valirx Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -22990.0% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 403.7 n/a
Pr/Book 1.4  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Valirx Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (2.72) (4,135.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (1.54) (3.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (1.68) (2.34)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (2.60) (3.06)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.01 (2.30) (2.01)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Valirx Company Announcements

Business Update 20-May-2024 12:00 RNS
Further re Final Results 16-May-2024 07:00 RNS
Final Results and Notice of AGM 15-May-2024 07:00 RNS

Valirx ShareCast News

ValiRx inks deal with Dundee Drug Discovery Unit 12-Feb-2024 ShareCast
ValiRx enters option deal with Ambrose Healthcare 05-Dec-2023 ShareCast
ValiRx enters partnership with StingRay Bio 10-Nov-2023 ShareCast

Valirx Top Newspaper Links

Business Digest 24-Sep-2006 Sunday Times

Latest Valirx Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Valirx Market Data

Currency UK Pounds
Share Price 3.13p
Change Today 0.075p
% Change 2.46 %
52 Week High 14.13
52 Week Low 1.90
Volume 142,606
Shares Issued 132.35m
Market Cap £4.14m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.12% below the market average27.12% below the market average27.12% below the market average27.12% below the market average27.12% below the market average
9.80% above the sector average9.80% above the sector average9.80% above the sector average9.80% above the sector average9.80% above the sector average
Price Trend
94.9% below the market average94.9% below the market average94.9% below the market average94.9% below the market average94.9% below the market average
88.68% below the sector average88.68% below the sector average88.68% below the sector average88.68% below the sector average88.68% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 24-May-2024

Time Volume / Share Price
10:57 74,762 @ 2.92p
09:33 2,191 @ 2.99p
09:32 20,000 @ 3.04p
09:29 10,000 @ 3.04p
08:59 10,000 @ 3.04p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page